Shingles Vaccine Linked to Reduced Dementia Risk in Women
Recent research reveals a compelling link between the shingles vaccine and a lower risk of dementia, especially among women. The study, which involved over 280,000 participants, indicates that vaccination can reduce dementia risk by 20%.
This significant finding highlights the potential of the shingles vaccine beyond its primary purpose of preventing shingles. Experts suggest that the vaccine may bolster the immune system, thus mitigating the effects of viral infections that can accelerate cognitive decline.
Notably, the protective effect appears to be more pronounced in women, possibly due to greater prevalence of autoimmune conditions among them. These insights open new avenues for understanding dementia and emphasize the importance of vaccination in older adults.
As dementia affects millions globally, the findings suggest that strategies focusing on viral prevention could play a crucial role in reducing cognitive decline. Further research is necessary to explore the underlying mechanisms and to confirm these promising results, underscoring the need for continued public health initiatives in vaccination efforts.
The press radar on this topic:
Study provided evidence: Shingles vaccination reduces the risk of dementia in women - n-tv.de
Shingles Vaccine Can Decrease Risk of Dementia, Study Finds
Getting vaccinated against shingles could reduce the risk of developing dementia
Welcome!

infobud.news is an AI-driven news aggregator that simplifies global news, offering customizable feeds in all languages for tailored insights into tech, finance, politics, and more. It provides precise, relevant news updates, overcoming conventional search tool limitations. Due to the diversity of news sources, it provides precise and relevant news updates, focusing entirely on the facts without influencing opinion. Read moreExpand